How Walgreens is supporting patients during Medicaid redeterminations

The latest stories trending on MedCity News.

ddg

Editor's Pick

Top Story How Walgreens Is Supporting Patients During Medicaid Redeterminations Now that Medicaid redeterminations have resumed, Walgreens is supporting patients by educating them about renewals and helping them navigate through the process, execs said at AHIP 2023 in Portland. Partnership Content Canada and the Midwest in Life Sciences, 75 Years in the Making Presented by MedCity News & Global Affairs Canada The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest. Learn More>> Calling All FemTech Startups Startups in this category are software and medical technology companies that are addressing various aspects of female physical and mental health. We are now accepting FemTech Pitch Perfect submissions for MedCity INVEST Digital Health, which is taking place on October 26, 2023 at Pegasus Park in Dallas, TX. Submit your application today.

Featured News

Bleeding Problems Prompt FDA Partial Hold on Tests of Mersana Cancer Drug For the second time in three months, Mersana Therapeutics is dealing with an FDA clinical hold. The partial hold on tests of its experimental ovarian cancer drug follows a full hold placed on an early-stage test of a different Mersana therapy in various types of solid tumors. INVEST Digital Health Conference in Dallas Will Probe True Value and Not Fanciful Valuation In an environment where capital isn't as easy to access, INVEST Digital Health conference will seek to arm you with the right connections and meaningful insight to navigate an environment where ROI is king. Hear from payers, providers, startups, life sciences executives, VCs and more. Medivis Snags $20M to Enhance Surgical Navigation With Augmented Reality Medivis recently raised $20 million in a Series A funding round that included investments from Mayo Clinic, Bob Iger and Kevin Durant. The New York City-based company's technology can be thought of as a "virtual GPS system" for surgeons — it helps them navigate complex anatomical landscapes during operations and gives them a more accurate, intuitive understanding of the anatomy with which they're dealing. Opinion: New Study Reaffirms Value of Hospice – Policymakers Must Act To Expand and Protect This Type of Care A new report by NORC at the University of Chicago reveals earlier enrollment in hospice and longer lengths of stay increase patient and family satisfaction while lowering total costs of care – reaffirming what hospice providers have known for years. How Should Providers Adapt to Telehealth's New Era? Most patients prefer in-person care to virtual, according to a recent report. This finding should drive health systems to refine their telehealth experiences — they should determine which type of visits are best-suited for the modality, and they should ensure their virtual care environments adopt a more human-centric design. Eli Lilly Puts Up $60M for In Vivo Gene-Editing Med for Cardiovascular Disease Eli Lilly's partnership with Verve Therapeutics covers the development of a preclinical therapy addressing a protein associated with cardiovascular disease risk. The in vivo gene-editing therapy is a potential one-time treatment. Don't Be Fooled by the 'Autonomous' Revenue Cycle Hype But what AI solutions can't do is magically eliminate the need for empowered registrars. Maximizing growth while improving efficiency requires both people and technologies.

Resources

Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World Presented by Allucent Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.

MedCity News • PO Box 901 • New York, NY unsubscribe